ASX - By Stock
|
PER |
Re:
Clean insights and information easily found
|
|
koenermann
|
157 |
36K |
5 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
157
|
36K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
koenermann
|
127 |
32K |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
127
|
32K
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
2 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
1 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
3 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
4 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long Covid-19 Collaboration Outcomes Presentation
|
|
koenermann
|
228 |
86K |
2 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
228
|
86K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
koenermann
|
122 |
34K |
3 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
122
|
34K
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
1 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
8 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
8
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
2 |
19/11/22 |
19/11/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
2
|
|
ASX - By Stock
|
PER |
Re:
ANP Value
|
|
koenermann
|
328 |
91K |
0 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
328
|
91K
|
0
|
|
ASX - By Stock
|
PER |
Re:
ANP Value
|
|
koenermann
|
328 |
91K |
10 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
328
|
91K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: Appendix 4E and Full Year Statutory Accounts
|
|
koenermann
|
150 |
48K |
4 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
150
|
48K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long Covid-19 Collaboration Outcomes Presentation
|
|
koenermann
|
228 |
86K |
3 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
228
|
86K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long Covid-19 Collaboration Outcomes Presentation
|
|
koenermann
|
228 |
86K |
3 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
228
|
86K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Voluntary Suspension
|
|
koenermann
|
109 |
41K |
2 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
109
|
41K
|
2
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
10 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
10
|
|
Charts
|
PER |
Re:
Chart
|
|
koenermann
|
5.9K |
2.3M |
4 |
06/08/22 |
06/08/22 |
Charts
|
5.9K
|
2.3M
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
1 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
0 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
0
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
1 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
1 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
4 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
koenermann
|
88 |
21K |
2 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
88
|
21K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
koenermann
|
88 |
21K |
3 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
88
|
21K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
koenermann
|
88 |
21K |
1 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
88
|
21K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to Present at the PPMD Annual Conference 2022
|
|
koenermann
|
88 |
21K |
1 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
88
|
21K
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
8 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
8
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
1 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
4 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
5 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
koenermann
|
3.5K |
1.0M |
1 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Long COVID-19 strategic collaboration with US Experts
|
|
koenermann
|
245 |
70K |
9 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
245
|
70K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Investor Presentation
|
|
koenermann
|
85 |
26K |
3 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
85
|
26K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Poster Presentation at 2022 MDA Conference
|
|
koenermann
|
67 |
21K |
8 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
67
|
21K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Ann: Poster Presentation at 2022 MDA Conference
|
|
koenermann
|
67 |
21K |
1 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
67
|
21K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Poster Presentation at 2022 MDA Conference
|
|
koenermann
|
67 |
21K |
0 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
67
|
21K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Poster Presentation at 2022 MDA Conference
|
|
koenermann
|
67 |
21K |
1 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
67
|
21K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Poster Presentation at 2022 MDA Conference
|
|
koenermann
|
67 |
21K |
3 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
67
|
21K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Poster Presentation at 2022 MDA Conference
|
|
koenermann
|
67 |
21K |
2 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
67
|
21K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to present at XIX International Conference on DMD
|
|
koenermann
|
24 |
7.2K |
2 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
24
|
7.2K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to present at XIX International Conference on DMD
|
|
koenermann
|
24 |
7.2K |
3 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
24
|
7.2K
|
3
|
|
ASX - By Stock
|
PER |
Re:
atl1102 in the Box seat re DMD. Sarepta fails .
|
|
koenermann
|
114 |
30K |
2 |
20/02/22 |
20/02/22 |
ASX - By Stock
|
114
|
30K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to present at XIX International Conference on DMD
|
|
koenermann
|
24 |
7.2K |
0 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
24
|
7.2K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to present at XIX International Conference on DMD
|
|
koenermann
|
24 |
7.2K |
6 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
24
|
7.2K
|
6
|
|
ASX - By Stock
|
PER |
Re:
atl1102 in the Box seat re DMD. Sarepta fails .
|
|
koenermann
|
114 |
30K |
3 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
114
|
30K
|
3
|
|
ASX - By Stock
|
PER |
Re:
EQUITY RESEARCH REPORT - WILSON dated 18 Jan 2022
|
|
koenermann
|
126 |
42K |
6 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
126
|
42K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 Toxicology Protocol submitted to US FDA
|
|
koenermann
|
31 |
11K |
6 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
31
|
11K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 Toxicology Protocol submitted to US FDA
|
|
koenermann
|
31 |
11K |
0 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
31
|
11K
|
0
|
|